Log In
BCIQ
Print this Print this
 

PNT2258

Also known as: PNT100

  Manage Alerts
Collapse Summary General Information
Company ProNAi Therapeutics Inc.
Description24-base phosphodiester DNA sequence targeting the B cell lymphoma 2 (BCL-2; BCL2) gene formulated with Marina Biotech's Smarticles liposomal delivery technology
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2)
Mechanism of ActionBcl-2 inhibitor; Gene silencing
Therapeutic ModalityNucleic acid: Linear DNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$11.1M

$1.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/15/2016

$11.1M

$1.0M

0

Get a free BioCentury trial today